Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00973921 · ClinicalTrials.gov registry record

Comparison of StentOptimizer With IntraVenous Ultrasound and 2D Quantitative Coronary Angiography

A clinical trial of Coronary Artery Disease, sponsored by Paieon.

Completed
Registry status
40
Enrollment target
1
Study location

NCT00973921 is a study of Coronary Artery Disease that has completed, run by Paieon. The registered enrollment target is 40 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00973921, a study of Coronary Artery Disease, has completed, sponsored by Paieon.

COMPLETED
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to determine the diagnostic efficiency and accuracy of using the StentOptimizer. The ability of StentOptimizer to influence post deployment treatment strategy will be assessed and compared to the IVUS system. In addition, the correlation of diameter measurements between the StentOptimizer, IVUS and 2D QCA will be assessed. The StentOptimizer software, IVUS and 2D QCA were all part of the clinical procedure outside the study. The analysis of post deployment treatment decisions and diameter measurements using those modalities retrospectively make this an observational study.

Conditions Studied

Study Locations (1)

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2009-09
Est. Completion 2010-03

Sponsor

Paieon

1 total trials

What the Registry Record Tells You About NCT00973921

The ClinicalTrials.gov registry entry for NCT00973921 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (97% lower). The listed sponsor is Paieon, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00973921 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00973921 about?

NCT00973921 is a clinical study titled "Comparison of StentOptimizer With IntraVenous Ultrasound and 2D Quantitative Coronary Angiography". The primary objective of this study is to determine the diagnostic efficiency and accuracy of using the StentOptimizer. The ability of StentOptimizer to influence post deployment treatment strategy will be assessed and compared to the IVUS system. In addition, the correlation of diameter measurement...

What is the current status of trial NCT00973921?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2009-09. Estimated completion is 2010-03.

What conditions does trial NCT00973921 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

Who is sponsoring clinical trial NCT00973921?

This trial is sponsored by Paieon, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00973921 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.